Synthekine Revenue and Competitors
Estimated Revenue & Valuation
- Synthekine's estimated annual revenue is currently $21.5M per year.
- Synthekine's estimated revenue per employee is $155,000
- Synthekine's total funding is $189.5M.
Employee Data
- Synthekine has 139 Employees.
- Synthekine grew their employee count by 15% last year.
Synthekine's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CEO | Reveal Email/Phone |
2 | VP Regulatory Affairs | Reveal Email/Phone |
3 | VP, Clinical Development | Reveal Email/Phone |
4 | VP, Research, Head Protein Sciences | Reveal Email/Phone |
5 | VP, Program Management | Reveal Email/Phone |
6 | VP, Business Development | Reveal Email/Phone |
7 | VP Quality Assurance | Reveal Email/Phone |
8 | VP Intellectual Property | Reveal Email/Phone |
9 | VP, Clinical Development Operations at Synthekine | Reveal Email/Phone |
10 | VP Process and Analytical Development | Reveal Email/Phone |
Synthekine Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $4.4M | 57 | -8% | $53M | N/A |
#2 | $21.2M | 137 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.3M | 15 | 15% | N/A | N/A |
#5 | $1.6M | 10 | -17% | N/A | N/A |
#6 | $0.7M | 9 | 50% | N/A | N/A |
#7 | $11.5M | 74 | -12% | N/A | N/A |
#8 | $0.4M | 275 | 10% | $236.7M | N/A |
#9 | $4M | 51 | -74% | $160M | N/A |
#10 | $2.3M | 15 | 15% | N/A | N/A |
What Is Synthekine?
Synthekine is an engineered cytokine therapeutics company developing disease-optimized treatments. The company uses immunological insights to guide targeted protein engineering to generate transformative medicines for cancer and autoimmune disorders. Using the principles of cytokine partial agonism and immunological specificity, Synthekine designs differentiated therapeutics to be both safe and efficacious. Its lead programs have shown promising efficacy and tolerability in preclinical studies, and it is developing additional cytokine partial agonists that selectively modulate key pathways of the immune system.
keywords:N/A
$189.5M
Total Funding
139
Number of Employees
$21.5M
Revenue (est)
15%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Synthekine News
Synthekine, founded by Garcia, is developing a candidate called STK-012 that aims to selectively stimulate a trimeric form of the IL-2...
--(BUSINESS WIRE)--Synthekine Inc., an engineered cytokine therapeutics company, today announced five poster presentations based on research...
Synthekine Inc., an engineered cytokine therapeutics company, today announced that it has closed an oversubscribed $107.5 million Series B financing. The round was co-led by Deerfield Management and Janus Henderson Investors, with participation from RA Capital Management, Rock Springs Capital, O ...
Other Companies in Menlo Park
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $32.3M | 140 | 6% | N/A |
#2 | N/A | 142 | 190% | N/A |
#3 | $21.7M | 144 | 5% | $108M |
#4 | $26.4M | 147 | -1% | N/A |
#5 | $48.6M | 155 | 6% | $318.8M |